Incyte Corp
INCYHealthcare|Biotechnology|USA
$93.59
-1.27 (-1.34%)
DCF (FCF)
$55.64
Tangible Book
$24.78
Graham Number
$61.53
Earnings Power
$50.38
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (498)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| CAGNONI PABLO J | President, R&D | 2026-03-17 | SELL | 18,667 | $94.24 | $1759.2K |
| CAGNONI PABLO J | President, R&D | 2026-02-19 | SELL | 18,668 | $100.91 | $1883.8K |
| Issa Mohamed Khairie | EVP, Head of US Oncology | 2026-01-07 | SELL | 10,856 | $109.07 | $1184.1K |
| Stein Steven H | EVP & Chief Medical Officer | 2026-01-05 | SELL | 15,634 | $101.7 | $1590K |
| Tray Thomas | Principal Accounting Officer | 2025-12-19 | SELL | 3,374 | $99.69 | $336.4K |
| Morrissey Michael James | EVP, Head of Tech. Operations | 2025-12-17 | SELL | 58,331 | $97.29 | $5675K |
| Mayes Patrick A | EVP & Chief Scientific Officer | 2025-12-11 | SELL | 5,808 | $95.55 | $555K |
| Stein Steven H | EVP & Chief Medical Officer | 2025-12-02 | SELL | 22,664 | $102.56 | $2324.4K |
| Tray Thomas | Principal Accounting Officer | 2025-11-24 | SELL | 769 | $102.78 | $79K |
| Denton Sheila A. | EVP & General Counsel | 2025-11-17 | SELL | 278 | $104.36 | $29K |
| Hoppenot Herve | Director | 2025-11-10 | SELL | 187,500 | $105.46 | $19773.8K |
| Stein Steven H | EVP & Chief Medical Officer | 2025-11-05 | SELL | 5,233 | $102.2 | $534.8K |
| Denton Sheila A. | EVP & General Counsel | 2025-11-04 | SELL | 598 | $101.36 | $60.6K |
| Heeson Lee | EVP, Head of Incyte Intl | 2025-11-03 | SELL | 3,074 | $94.02 | $289K |
| Denton Sheila A. | EVP & General Counsel | 2025-10-15 | SELL | 277 | $85.13 | $23.6K |
| Denton Sheila A. | EVP & General Counsel | 2025-10-03 | SELL | 4,100 | $85.85 | $352K |
| Denton Sheila A. | EVP & General Counsel | 2025-09-16 | SELL | 278 | $83.15 | $23.1K |
| Denton Sheila A. | EVP & General Counsel | 2025-09-02 | SELL | 598 | $84.97 | $50.8K |
| Denton Sheila A. | EVP & General Counsel | 2025-08-15 | SELL | 277 | $86.81 | $24K |
| Denton Sheila A. | EVP & General Counsel | 2025-08-04 | SELL | 598 | $75.77 | $45.3K |
| Stein Steven H | EVP & Chief Medical Officer | 2025-07-21 | SELL | 3,706 | $67.94 | $251.8K |
| Flannelly Barry P | EVP & General Manager US | 2025-07-16 | SELL | 1,340 | $68.36 | $91.6K |
| Iyengar Vijay K | EVP, GMAPPS | 2025-07-16 | SELL | 983 | $68.36 | $67.2K |
| Denton Sheila A. | EVP & General Counsel | 2025-07-16 | SELL | 4,115 | $69.57 | $286.3K |
| Flannelly Barry P | EVP & General Manager US | 2025-07-15 | SELL | 1,192 | $69.86 | $83.3K |
| Iyengar Vijay K | EVP, GMAPPS | 2025-07-15 | SELL | 1,177 | $69.86 | $82.2K |
| Stein Steven H | EVP & Chief Medical Officer | 2025-07-14 | SELL | 14,952 | $68.47 | $1023.8K |
| Flannelly Barry P | EVP & General Manager US | 2025-07-03 | SELL | 10,903 | $68.15 | $743K |
| Iyengar Vijay K | EVP, GMAPPS | 2025-07-03 | SELL | 8,617 | $68.15 | $587.2K |
| Denton Sheila A. | EVP & General Counsel | 2025-07-02 | SELL | 599 | $68.61 | $41.1K |
| Denton Sheila A. | EVP & General Counsel | 2025-06-03 | SELL | 1,795 | $68 | $122.1K |
| Tray Thomas | Principal Accounting Officer | 2025-06-02 | SELL | 1,614 | $65.38 | $105.5K |
| Flannelly Barry P | EVP & General Manager US | 2025-03-14 | SELL | 19,807 | $67.69 | $1340.7K |
| Denton Sheila A. | EVP & General Counsel | 2025-03-04 | SELL | 599 | $69.99 | $41.9K |
| Denton Sheila A. | EVP & General Counsel | 2025-02-26 | SELL | 14,069 | $74.07 | $1042.1K |
| Stein Steven H | EVP & Chief Medical Officer | 2025-01-21 | SELL | 12,352 | $72.69 | $897.9K |
| Tray Thomas | Principal Accounting Officer | 2024-12-16 | SELL | 1,300 | $69.98 | $91K |
| Iyengar Vijay K | EVP, GMAPPS | 2024-11-29 | SELL | 6,043 | $75.38 | $455.5K |
| Flannelly Barry P | EVP & General Manager US | 2024-11-06 | SELL | 3,680 | $79.68 | $293.2K |
| Tray Thomas | Principal Accounting Officer | 2024-09-13 | SELL | 954 | $63.11 | $60.2K |
| Dickinson Jonathan Elliott | EVP, General Manager, Europe | 2024-09-12 | SELL | 8,450 | $62.36 | $526.9K |
| Stein Steven H | EVP & Chief Medical Officer | 2024-08-12 | SELL | 11,608 | $60.63 | $703.8K |
| Iyengar Vijay K | EVP, GMAPPS | 2024-07-25 | SELL | 15,571 | $70 | $1090K |
| Flannelly Barry P | EVP & General Manager US | 2024-07-16 | SELL | 1,306 | $64.19 | $83.8K |
| Flannelly Barry P | EVP & General Manager US | 2024-07-09 | SELL | 8,148 | $60 | $488.9K |
| Flannelly Barry P | EVP & General Manager US | 2024-06-12 | SELL | 19,164 | $60 | $1149.8K |
| Tray Thomas | Principal Accounting Officer | 2024-06-06 | SELL | 1,093 | $58.91 | $64.4K |
| Stein Steven H | EVP & Chief Medical Officer | 2024-01-03 | SELL | 7,365 | $65.51 | $482.5K |
| Iyengar Vijay K | EVP, GMAPPS | 2024-01-02 | SELL | 657 | $65 | $42.7K |
| Tray Thomas | Principal Accounting Officer | 2023-12-13 | SELL | 1,277 | $61.55 | $78.6K |
| SWAIN PAULA J | EVP, Human Resources | 2023-09-01 | SELL | 8,449 | $65.13 | $550.3K |
| Stein Steven H | EVP & Chief Medical Officer | 2023-08-01 | SELL | 21,511 | $63.28 | $1361.2K |
| Pasquale Maria E | EVP & General Counsel | 2023-01-30 | SELL | 60,024 | $84.74 | $5086.4K |
| Iyengar Vijay K | EVP, GMAPPS | 2023-01-26 | SELL | 7,000 | $85 | $595K |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 2023-01-26 | SELL | 2,419 | $85 | $205.6K |
| Stein Steven H | EVP & Chief Medical Officer | 2023-01-04 | SELL | 28,399 | $79.78 | $2265.7K |
| Iyengar Vijay K | EVP, GMAPPS | 2022-12-23 | SELL | 17,324 | $80.8 | $1399.8K |
| Tray Thomas | Principal Accounting Officer | 2022-12-19 | SELL | 1,223 | $82.16 | $100.5K |
| Tray Thomas | Principal Accounting Officer | 2022-07-22 | SELL | 1,564 | $83.13 | $130K |
| Iyengar Vijay K | EVP, GMAPPS | 2022-07-07 | SELL | 5,787 | $79.38 | $459.4K |
| Flannelly Barry P | EVP & General Manager US | 2022-07-07 | SELL | 2,873 | $79.38 | $228.1K |
| Flannelly Barry P | EVP & General Manager US | 2022-04-08 | SELL | 43,993 | $83.49 | $3673K |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 2022-03-10 | BUY | 389,080 | $72.24 | $28107.1K |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 2022-02-22 | BUY | 525,804 | $67.96 | $35733.6K |
| Dickinson Jonathan Elliott | EVP, General Manager, Europe | 2022-01-31 | SELL | 7,375 | $74.19 | $547.2K |
| SWAIN PAULA J | EVP, Human Resources | 2022-01-07 | SELL | 10,870 | $73.31 | $796.9K |
| DIXON WENDY L | Director | 2021-12-23 | SELL | 20,000 | $22.05 | $441K |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 2021-12-17 | BUY | 1,595,519 | $72.43 | $115563.4K |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 2021-10-01 | SELL | 389 | $68.67 | $26.7K |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 2021-09-01 | SELL | 388 | $76.71 | $29.8K |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 2021-08-02 | SELL | 389 | $77.49 | $30.1K |
| Iyengar Vijay K | EVP GPS, BD, & Licensing | 2021-07-29 | SELL | 4,911 | $78.29 | $384.5K |
| Wenqing Yao | EVP, Head of Discovery Chem | 2021-06-29 | SELL | 27,194 | $85.37 | $2321.6K |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 2021-06-10 | SELL | 3,845 | $87 | $334.5K |
| Morrissey Michael James | EVP, Head of Tech. Operations | 2021-03-29 | SELL | 20,000 | $81.08 | $1621.6K |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 2021-03-01 | SELL | 395 | $79.73 | $31.5K |
| Hoppenot Herve | President | 2021-02-23 | BUY | 12,925 | $77.37 | $1000K |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 2021-02-01 | SELL | 1,356 | $90 | $122K |
| Wenqing Yao | EVP, Head of Discovery Chem | 2021-01-25 | SELL | 21,545 | $100 | $2154.5K |
| Stein Steven H | EVP & Chief Medical Officer | 2021-01-25 | SELL | 3,795 | $100 | $379.5K |
| Iyengar Vijay K | EVP GPS, BD, & Licensing | 2021-01-25 | SELL | 5,116 | $99 | $506.5K |
| Flannelly Barry P | EVP & General Manager US | 2021-01-25 | SELL | 2,744 | $100 | $274.4K |
| BIENAIME JEAN JACQUES | Director | 2020-11-10 | SELL | 798 | $83 | $66.2K |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 2020-11-06 | SELL | 961 | $85.17 | $81.8K |
| Flannelly Barry P | EVP & General Manager US | 2020-11-02 | SELL | 20,000 | $86.6 | $1732K |
| Pasquale Maria E | EVP & General Counsel | 2020-10-09 | SELL | 1,423 | $95 | $135.2K |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 2020-10-06 | SELL | 961 | $91.97 | $88.4K |
| Pasquale Maria E | EVP & General Counsel | 2020-09-10 | SELL | 2,193 | $90.83 | $199.2K |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 2020-09-08 | SELL | 961 | $88.94 | $85.5K |
| DIXON WENDY L | Director | 2020-08-27 | SELL | 20,000 | $94.51 | $1890.2K |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 2020-08-06 | SELL | 961 | $97.8 | $94K |
| Stein Steven H | EVP & Chief Medical Officer | 2020-07-16 | SELL | 766 | $103.83 | $79.5K |
| Iyengar Vijay K | EVP GPS, BD, & Licensing | 2020-07-08 | SELL | 3,595 | $108.06 | $388.5K |
| Stein Steven H | EVP & Chief Medical Officer | 2020-07-08 | SELL | 14,769 | $109.52 | $1617.5K |
| Hoppenot Herve | President | 2020-07-07 | SELL | 89,771 | $110 | $9874.8K |
| Wenqing Yao | EVP, Head of Discovery Chem | 2020-07-06 | SELL | 16,553 | $107.32 | $1776.5K |
| Stein Steven H | EVP & Chief Medical Officer | 2020-07-06 | SELL | 36,124 | $107.25 | $3874.3K |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 2020-07-06 | SELL | 961 | $106.58 | $102.4K |
| Hoppenot Herve | President | 2020-06-26 | SELL | 124,148 | $102.91 | $12776.1K |
| Trower Paul | Principal Accounting Officer | 2020-06-23 | SELL | 6,943 | $110 | $763.7K |
| Flannelly Barry P | EVP & General Manager US | 2020-06-23 | SELL | 400 | $110 | $44K |
| Dickinson Jonathan Elliott | EVP, General Manager, Europe | 2020-06-22 | SELL | 9,000 | $105.31 | $947.8K |
| Pasquale Maria E | EVP & General Counsel | 2020-06-19 | SELL | 1,423 | $100 | $142.3K |
| Iyengar Vijay K | EVP GPS, BD, & Licensing | 2020-06-19 | SELL | 7,866 | $105 | $825.9K |
| Flannelly Barry P | EVP & General Manager US | 2020-06-19 | SELL | 7,181 | $105 | $754K |
| Pasquale Maria E | EVP & General Counsel | 2020-06-10 | SELL | 3,615 | $94.51 | $341.7K |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 2020-06-08 | SELL | 961 | $91.87 | $88.3K |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 2020-05-28 | BUY | 2 | $102.55 | $0.2K |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 2020-05-06 | SELL | 961 | $96.84 | $93.1K |
| Pasquale Maria E | EVP & General Counsel | 2020-04-17 | SELL | 18,976 | $97.5 | $1850.2K |
| Trower Paul | Principal Accounting Officer | 2020-04-17 | SELL | 1,143 | $100 | $114.3K |
| Flannelly Barry P | EVP & General Manager US | 2020-04-17 | SELL | 6,583 | $100 | $658.3K |
| Pasquale Maria E | EVP & General Counsel | 2020-04-14 | SELL | 18,792 | $89.78 | $1687.1K |
| Pasquale Maria E | EVP & General Counsel | 2020-04-06 | SELL | 1,842 | $85 | $156.6K |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 2020-04-06 | SELL | 3,844 | $85 | $326.7K |
| SWAIN PAULA J | EVP, Human Resources | 2020-03-31 | SELL | 2,329 | $71.44 | $166.4K |
| SWAIN PAULA J | EVP, Human Resources | 2020-02-19 | SELL | 2,500 | $80 | $200K |
| Wenqing Yao | EVP, Head of Discovery Chem | 2020-02-05 | SELL | 17,542 | $75.97 | $1332.7K |
| SWAIN PAULA J | EVP, Human Resources | 2020-01-15 | SELL | 2,500 | $81.12 | $202.8K |
| SWAIN PAULA J | EVP, Human Resources | 2019-12-16 | SELL | 2,500 | $91.61 | $229K |
| Wenqing Yao | EVP, Head of Discovery Chem | 2019-12-02 | SELL | 20,000 | $95 | $1900K |
| Iyengar Vijay K | EVP GPS, BD, & Licensing | 2019-12-02 | SELL | 7,866 | $95 | $747.3K |
| Flannelly Barry P | EVP & General Manager US | 2019-12-02 | SELL | 7,182 | $95 | $682.3K |
| Flannelly Barry P | EVP & General Manager US | 2019-11-25 | SELL | 2,142 | $90 | $192.8K |
| Wenqing Yao | EVP, Head of Discovery Chem | 2019-11-25 | SELL | 15,000 | $90 | $1350K |
| Trower Paul | Principal Accounting Officer | 2019-11-25 | SELL | 15,000 | $90 | $1350K |
| SWAIN PAULA J | EVP, Human Resources | 2019-11-15 | SELL | 2,500 | $86.46 | $216.2K |
| DIXON WENDY L | Director | 2019-11-08 | SELL | 53,334 | $83.92 | $4475.8K |
| Trower Paul | Principal Accounting Officer | 2019-11-01 | SELL | 8,500 | $85 | $722.5K |
| Wenqing Yao | EVP, Head of Discovery Chem | 2019-11-01 | SELL | 7,960 | $85 | $676.6K |
| Iyengar Vijay K | EVP GPS, BD, & Licensing | 2019-10-29 | SELL | 930 | $85 | $79.1K |
| Wenqing Yao | EVP, Head of Discovery Chem | 2019-10-29 | SELL | 2,040 | $85 | $173.4K |
| Trower Paul | Principal Accounting Officer | 2019-10-29 | SELL | 16,500 | $80.45 | $1327.4K |
| SWAIN PAULA J | EVP, Human Resources | 2019-10-22 | SELL | 2,500 | $80 | $200K |
| SWAIN PAULA J | EVP, Human Resources | 2019-09-18 | SELL | 2,500 | $80 | $200K |
| Flannelly Barry P | EVP & General Manager US | 2019-09-17 | SELL | 2,491 | $77.71 | $193.6K |
| SWAIN PAULA J | EVP, Human Resources | 2019-08-15 | SELL | 2,500 | $80.96 | $202.4K |
| FRIEDMAN PAUL A | Director | 2019-08-06 | SELL | 100,000 | $82.69 | $8269K |
| BIENAIME JEAN JACQUES | Director | 2019-08-02 | SELL | 1,724 | $85.07 | $146.7K |
| Flannelly Barry P | EVP & General Manager US | 2019-07-17 | SELL | 959 | $79.91 | $76.6K |
| SWAIN PAULA J | EVP, Human Resources | 2019-07-15 | SELL | 2,500 | $80 | $200K |
| Stein Steven H | EVP & Chief Medical Officer | 2019-06-24 | SELL | 8,357 | $87.96 | $735.1K |
| SWAIN PAULA J | EVP, Human Resources | 2019-06-17 | SELL | 2,500 | $80 | $200K |
| SWAIN PAULA J | EVP, Human Resources | 2019-04-01 | SELL | 10,000 | $87.01 | $870.1K |
| SWAIN PAULA J | EVP, Human Resources | 2019-03-01 | SELL | 10,000 | $86.68 | $866.8K |
| SWAIN PAULA J | EVP, Human Resources | 2019-02-01 | SELL | 10,000 | $81.19 | $811.9K |
| Flannelly Barry P | EVP & General Manager US | 2019-01-28 | SELL | 1,000 | $80 | $80K |
| Wenqing Yao | EVP, Head of Discovery Chem | 2019-01-17 | SELL | 15,354 | $77.61 | $1191.6K |
| Trower Paul | Principal Accounting Officer | 2019-01-15 | SELL | 5,813 | $75 | $436K |
| Flannelly Barry P | EVP & General Manager US | 2019-01-08 | SELL | 1,714 | $75.56 | $129.5K |
| Wenqing Yao | EVP, Head of Discovery Chem | 2019-01-07 | SELL | 10,000 | $75 | $750K |
| Trower Paul | Principal Accounting Officer | 2019-01-07 | SELL | 9,187 | $75 | $689K |
| SWAIN PAULA J | EVP, Human Resources | 2019-01-04 | SELL | 30,000 | $70 | $2100K |
| BIENAIME JEAN JACQUES | Director | 2018-11-08 | BUY | 1,000 | $68.77 | $68.8K |
| Trower Paul | Principal Accounting Officer | 2018-10-03 | SELL | 10,000 | $70 | $700K |
| SWAIN PAULA J | EVP, Human Resources | 2018-10-03 | SELL | 10,000 | $70 | $700K |
| Flannelly Barry P | EVP & General Manager US | 2018-10-03 | SELL | 1,000 | $70 | $70K |
| SWAIN PAULA J | EVP, Human Resources | 2018-09-04 | SELL | 10,000 | $73.21 | $732.1K |
| SWAIN PAULA J | EVP, Human Resources | 2018-08-21 | SELL | 10,000 | $70 | $700K |
| SWAIN PAULA J | EVP, Human Resources | 2018-07-09 | SELL | 10,000 | $71.11 | $711.1K |
| Iyengar Vijay K | EVP GPS, BD, & Licensing | 2018-07-09 | SELL | 606 | $71.34 | $43.2K |
| Hoppenot Herve | President | 2018-05-02 | BUY | 15,000 | $60.94 | $914.1K |
| SWAIN PAULA J | EVP, Human Resources | 2018-04-30 | SELL | 80,000 | $62.43 | $4994.4K |
| GRYSKA DAVID W | Executive Vice President, CFO | 2018-02-21 | SELL | 1,952 | $85.56 | $167K |
| Huber Reid M | EVP, Chief Scientific Officer | 2018-02-21 | SELL | 1,958 | $85.55 | $167.5K |
| GRYSKA DAVID W | Executive Vice President, CFO | 2018-01-05 | SELL | 6,760 | $98.87 | $668.4K |
| Iyengar Vijay K | EVP GPS, BD, & Licensing | 2018-01-02 | SELL | 5,000 | $97.26 | $486.3K |
| Huber Reid M | EVP, Chief Scientific Officer | 2017-12-01 | SELL | 696 | $98.01 | $68.2K |
| FRIEDMAN PAUL A | Director | 2017-11-16 | SELL | 28,507 | $105.24 | $3000.1K |
| GRYSKA DAVID W | Executive Vice President, CFO | 2017-11-02 | SELL | 3,915 | $105.63 | $413.5K |
| Hoppenot Herve | President | 2017-09-18 | SELL | 70,502 | $119.45 | $8421.5K |
| Flannelly Barry P | EVP & General Manager US | 2017-09-14 | SELL | 714 | $124.25 | $88.7K |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 2017-09-08 | BUY | 100,000 | $132 | $13200K |
| Trower Paul | Principal Accounting Officer | 2017-09-05 | SELL | 3,000 | $138.41 | $415.2K |
| Siegel Eric H. | EVP, General Counsel | 2017-09-01 | SELL | 1,820 | $137.4 | $250.1K |
| SWAIN PAULA J | EVP, Human Resources | 2017-08-31 | SELL | 20,000 | $140 | $2800K |
| Stein Steven H | EVP & Chief Medical Officer | 2017-08-29 | SELL | 2,111 | $125 | $263.9K |
| Trower Paul | Principal Accounting Officer | 2017-08-04 | SELL | 3,000 | $125.25 | $375.8K |
| Siegel Eric H. | EVP, General Counsel | 2017-08-01 | SELL | 1,820 | $132.92 | $241.9K |
| Stein Steven H | EVP & Chief Medical Officer | 2017-07-20 | SELL | 6,485 | $131.09 | $850.1K |
| Trower Paul | Principal Accounting Officer | 2017-07-05 | SELL | 3,000 | $126.18 | $378.5K |
| Siegel Eric H. | EVP, General Counsel | 2017-07-03 | SELL | 1,820 | $126.2 | $229.7K |
| GRYSKA DAVID W | Executive Vice President, CFO | 2017-06-30 | SELL | 599 | $129.74 | $77.7K |
| Stein Steven H | EVP & Chief Medical Officer | 2017-06-20 | SELL | 9,883 | $125 | $1235.4K |
| GRYSKA DAVID W | Executive Vice President, CFO | 2017-06-12 | SELL | 16,756 | $116.6 | $1953.7K |
| Trower Paul | Principal Accounting Officer | 2017-06-05 | SELL | 3,000 | $132.5 | $397.5K |
| Siegel Eric H. | EVP, General Counsel | 2017-06-01 | SELL | 1,820 | $130 | $236.6K |
| BIENAIME JEAN JACQUES | Director | 2017-05-31 | BUY | 500 | $131.8 | $65.9K |
| BIENAIME JEAN JACQUES | Director | 2017-05-15 | BUY | 500 | $115 | $57.5K |
| Huber Reid M | EVP, Chief Scientific Officer | 2017-05-08 | SELL | 8,577 | $119.21 | $1022.5K |
| Trower Paul | Principal Accounting Officer | 2017-05-05 | SELL | 3,000 | $121.7 | $365.1K |
| Flannelly Barry P | EVP & General Manager US | 2017-05-01 | SELL | 5,296 | $124.73 | $660.6K |
| Siegel Eric H. | EVP, General Counsel | 2017-05-01 | SELL | 1,820 | $124.73 | $227K |
| GRYSKA DAVID W | Executive Vice President, CFO | 2017-04-28 | SELL | 1,389 | $124.26 | $172.6K |
| BIENAIME JEAN JACQUES | Director | 2017-04-28 | BUY | 500 | $124.26 | $62.1K |
| BIENAIME JEAN JACQUES | Director | 2017-04-13 | BUY | 1,000 | $139.66 | $139.7K |
| Siegel Eric H. | EVP, General Counsel | 2017-04-10 | SELL | 4,043 | $140.18 | $566.7K |
| GRYSKA DAVID W | Executive Vice President, CFO | 2017-04-10 | SELL | 41,528 | $138 | $5730.9K |
| BIENAIME JEAN JACQUES | Director | 2017-04-07 | BUY | 1,000 | $139.48 | $139.5K |
| Stein Steven H | EVP & Chief Medical Officer | 2017-04-07 | SELL | 32,000 | $137.88 | $4412.2K |
| BROOKE PAUL A | Director | 2017-03-17 | SELL | 20,000 | $147.75 | $2955K |
| FRIEDMAN PAUL A | Director | 2017-03-17 | SELL | 50,000 | $148.72 | $7436K |
| Huber Reid M | EVP, Chief Scientific Officer | 2017-02-27 | SELL | 2,008 | $131.88 | $264.8K |
| FRIEDMAN PAUL A | Director | 2017-02-23 | SELL | 50,000 | $120.32 | $6016K |
| Huber Reid M | EVP, Chief Scientific Officer | 2017-01-09 | SELL | 11,739 | $113.55 | $1333K |
| SWAIN PAULA J | EVP, Human Resources | 2016-11-15 | SELL | 10,000 | $103.26 | $1032.6K |
| Huber Reid M | EVP, Chief Scientific Officer | 2016-11-09 | SELL | 2,715 | $109.95 | $298.5K |
| SWAIN PAULA J | EVP, Human Resources | 2016-10-20 | SELL | 10,000 | $90 | $900K |
| Huber Reid M | EVP, Chief Scientific Officer | 2016-10-07 | SELL | 11,709 | $96.4 | $1128.7K |
| Flannelly Barry P | EVP & General Manager US | 2016-10-07 | SELL | 24,204 | $97 | $2347.8K |
| SWAIN PAULA J | EVP, Human Resources | 2016-09-23 | SELL | 20,000 | $90 | $1800K |
| Huber Reid M | EVP, Chief Scientific Officer | 2016-08-02 | SELL | 10,000 | $87.96 | $879.6K |
| SWAIN PAULA J | EVP, Human Resources | 2016-07-29 | SELL | 60,000 | $90 | $5400K |
| BAKER JULIAN | Director, 10% Owner | 2016-03-17 | BUY | 800,000 | $63.98 | $51184K |
| BAKER JULIAN | Director, 10% Owner | 2016-02-25 | BUY | 64,290 | $70.79 | $4551.1K |
| BAKER JULIAN | Director, 10% Owner | 2016-02-16 | BUY | 887,165 | $69.87 | $61986.2K |
| BAKER JULIAN | Director, 10% Owner | 2016-02-12 | BUY | 2,251,427 | $63.53 | $143033.2K |
| SWAIN PAULA J | EVP, Human Resources | 2016-01-15 | SELL | 13,531 | $76.96 | $1041.3K |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2016-01-06 | SELL | 3,937 | $101.86 | $401K |
| Siegel Eric H. | EVP, General Counsel | 2015-12-10 | SELL | 1,936 | $107.96 | $209K |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-12-07 | SELL | 3,937 | $106.18 | $418K |
| FRIEDMAN PAUL A | Director | 2015-11-18 | SELL | 225,000 | $113.83 | $25611.8K |
| Siegel Eric H. | EVP, General Counsel | 2015-11-10 | SELL | 2,222 | $104.86 | $233K |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-11-06 | SELL | 3,936 | $116.51 | $458.6K |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-11-03 | SELL | 5,786 | $124.78 | $722K |
| Siegel Eric H. | EVP, General Counsel | 2015-10-13 | SELL | 2,222 | $101.49 | $225.5K |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-10-06 | SELL | 3,937 | $122.29 | $481.5K |
| Huber Reid M | EVP, Chief Scientific Officer | 2015-09-21 | SELL | 10,000 | $124.29 | $1242.9K |
| Siegel Eric H. | EVP, General Counsel | 2015-09-16 | SELL | 2,222 | $130.69 | $290.4K |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-09-11 | SELL | 4,301 | $130 | $559.1K |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-09-08 | SELL | 3,937 | $118.9 | $468.1K |
| Siegel Eric H. | EVP, General Counsel | 2015-08-13 | SELL | 2,222 | $107.69 | $239.3K |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-08-06 | SELL | 3,936 | $111.95 | $440.6K |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-07-15 | SELL | 12,850 | $116.7 | $1499.6K |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-07-15 | SELL | 70,217 | $120 | $8426K |
| Siegel Eric H. | EVP, General Counsel | 2015-07-14 | SELL | 2,222 | $113.61 | $252.4K |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-07-06 | SELL | 3,937 | $107 | $421.3K |
| Daly James M | EVP, Chief Commercial Officer | 2015-06-23 | SELL | 11,691 | $108.24 | $1265.4K |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-06-19 | SELL | 20,000 | $108.13 | $2162.6K |
| Siegel Eric H. | EVP, General Counsel | 2015-06-12 | SELL | 2,223 | $105.31 | $234.1K |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-06-08 | SELL | 3,937 | $107.58 | $423.5K |
| FRIEDMAN PAUL A | Director | 2015-05-27 | SELL | 196,751 | $107.23 | $21097.6K |
| Daly James M | EVP, Chief Commercial Officer | 2015-05-26 | SELL | 12,093 | $106.4 | $1286.7K |
| FRIEDMAN PAUL A | Director | 2015-05-22 | SELL | 102,243 | $108.22 | $11064.7K |
| Siegel Eric H. | EVP, General Counsel | 2015-05-14 | SELL | 2,222 | $104.99 | $233.3K |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-05-06 | SELL | 7,412 | $99.43 | $737K |
| Daly James M | EVP, Chief Commercial Officer | 2015-04-23 | SELL | 36,941 | $107.67 | $3977.4K |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-04-17 | SELL | 7,150 | $102.04 | $729.6K |
| Siegel Eric H. | EVP, General Counsel | 2015-04-14 | SELL | 2,222 | $98.72 | $219.4K |
| SWAIN PAULA J | EVP, Human Resources | 2015-04-13 | SELL | 16,469 | $96.29 | $1585.8K |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-04-13 | SELL | 23,000 | $95.18 | $2189.1K |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-04-07 | SELL | 20,031 | $90.13 | $1805.4K |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-04-06 | SELL | 25,000 | $88.77 | $2219.3K |
| Chardonnet Laurent | Vice President and Treasurer | 2015-03-30 | SELL | 113,776 | $93.64 | $10654K |
| Huber Reid M | EVP, Chief Scientific Officer | 2015-03-30 | SELL | 34,263 | $93.66 | $3209.1K |
| SWAIN PAULA J | EVP, Human Resources | 2015-03-16 | SELL | 17,500 | $89.97 | $1574.5K |
| ARIKO BARRY A | Director | 2015-03-12 | SELL | 80,000 | $89.27 | $7141.6K |
| Siegel Eric H. | EVP, General Counsel | 2015-03-12 | SELL | 2,222 | $89.72 | $199.4K |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-03-06 | SELL | 25,000 | $89.91 | $2247.8K |
| Siegel Eric H. | EVP, General Counsel | 2015-03-05 | SELL | 13,333 | $90 | $1200K |
| DE SCHUTTER RICHARD U | Chairman | 2015-03-05 | SELL | 40,000 | $92.09 | $3683.6K |
| Siegel Eric H. | EVP, General Counsel | 2015-02-25 | SELL | 13,333 | $85 | $1133.3K |
| Daly James M | EVP, Chief Commercial Officer | 2015-02-24 | SELL | 11,112 | $82.19 | $913.3K |
| ARIKO BARRY A | Director | 2015-02-18 | SELL | 20,000 | $78.43 | $1568.6K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2015-02-17 | SELL | 12,000 | $76.9 | $922.8K |
| SWAIN PAULA J | EVP, Human Resources | 2015-02-17 | SELL | 17,500 | $76.9 | $1345.8K |
| FRIEDMAN PAUL A | Director | 2015-02-13 | SELL | 120,000 | $74.32 | $8918.4K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2015-02-06 | SELL | 25,000 | $75.11 | $1877.8K |
| Siegel Eric H. | EVP, General Counsel | 2015-01-26 | SELL | 13,542 | $79.85 | $1081.3K |
| Daly James M | EVP, Chief Commercial Officer | 2015-01-23 | SELL | 11,109 | $77.68 | $862.9K |
| SWAIN PAULA J | EVP, Human Resources | 2015-01-20 | SELL | 17,500 | $74.17 | $1298K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2015-01-16 | SELL | 12,000 | $73.07 | $876.8K |
| Siegel Eric H. | EVP, General Counsel | 2015-01-08 | SELL | 15,626 | $75 | $1172K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2015-01-06 | SELL | 25,000 | $71.84 | $1796K |
| SWAIN PAULA J | EVP, Human Resources | 2015-01-05 | SELL | 17,500 | $73.9 | $1293.3K |
| Daly James M | EVP, Chief Commercial Officer | 2014-12-23 | SELL | 11,113 | $74.43 | $827.1K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-12-16 | SELL | 12,000 | $72.36 | $868.3K |
| DE SCHUTTER RICHARD U | Chairman | 2014-12-02 | SELL | 50,000 | $74.89 | $3744.5K |
| Daly James M | EVP, Chief Commercial Officer | 2014-11-24 | SELL | 11,111 | $74.08 | $823.1K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-11-17 | SELL | 12,000 | $69.97 | $839.6K |
| FRIEDMAN PAUL A | Director | 2014-11-06 | SELL | 185,653 | $67.87 | $12600.3K |
| Daly James M | EVP, Chief Commercial Officer | 2014-10-23 | SELL | 11,111 | $53.49 | $594.3K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-10-16 | SELL | 8,000 | $49.03 | $392.2K |
| Daly James M | EVP, Chief Commercial Officer | 2014-09-23 | SELL | 11,111 | $47.65 | $529.4K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-09-16 | SELL | 8,000 | $47.58 | $380.6K |
| Daly James M | EVP, Chief Commercial Officer | 2014-08-25 | SELL | 11,111 | $51.96 | $577.3K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-08-18 | SELL | 8,000 | $51.97 | $415.8K |
| Daly James M | EVP, Chief Commercial Officer | 2014-07-23 | SELL | 11,111 | $48.54 | $539.3K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-07-16 | SELL | 8,000 | $48.15 | $385.2K |
| Daly James M | EVP, Chief Commercial Officer | 2014-06-23 | SELL | 11,111 | $56.03 | $622.5K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-06-16 | SELL | 8,000 | $53.88 | $431K |
| HASTINGS DAVID C | CFO | 2014-06-05 | SELL | 200,000 | $52.73 | $10546K |
| Daly James M | EVP, Chief Commercial Officer | 2014-05-23 | SELL | 11,111 | $48.48 | $538.7K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-05-16 | SELL | 8,000 | $50.68 | $405.4K |
| Chardonnet Laurent | Vice President and Treasurer | 2014-05-12 | SELL | 2,058 | $54 | $111.1K |
| Chardonnet Laurent | Vice President and Treasurer | 2014-05-02 | SELL | 34,000 | $51.55 | $1752.7K |
| Daly James M | EVP, Chief Commercial Officer | 2014-04-23 | SELL | 30,555 | $47.71 | $1457.8K |
| FRIEDMAN PAUL A | Director | 2014-02-20 | SELL | 33,354 | $63.51 | $2118.3K |
| FRIEDMAN PAUL A | Director | 2014-02-19 | SELL | 771,182 | $65.65 | $50628.1K |
| DE SCHUTTER RICHARD U | Chairman | 2014-02-19 | SELL | 50,000 | $65.53 | $3276.5K |
| HASTINGS DAVID C | CFO | 2014-02-18 | SELL | 275,000 | $65.86 | $18111.5K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-02-14 | SELL | 231,096 | $66.34 | $15330.9K |
| ARIKO BARRY A | Director | 2014-02-13 | SELL | 10,000 | $66.49 | $664.9K |
| SWAIN PAULA J | EVP, Human Resources | 2014-02-13 | SELL | 216,967 | $66.73 | $14478.2K |
| Siegel Eric H. | EVP, General Counsel | 2014-02-13 | SELL | 56,042 | $66.67 | $3736.3K |
| Chardonnet Laurent | Vice President and Treasurer | 2014-02-13 | SELL | 98,334 | $66.28 | $6517.6K |
| Daly James M | EVP, Chief Commercial Officer | 2014-02-13 | SELL | 158,331 | $66.49 | $10527.4K |
| WHITFIELD ROY A | Director | 2013-11-18 | SELL | 50,000 | $47.37 | $2368.5K |
| FRIEDMAN PAUL A | CEO | 2013-09-10 | SELL | 376,789 | $37.32 | $14061.8K |
| Chardonnet Laurent | Vice President and Treasurer | 2013-09-09 | SELL | 44,834 | $37.31 | $1672.8K |
| HASTINGS DAVID C | CFO | 2013-09-06 | SELL | 100,000 | $35.16 | $3516K |
| Siegel Eric H. | EVP, General Counsel | 2013-09-06 | SELL | 55,978 | $35.17 | $1968.7K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2013-09-06 | SELL | 25,000 | $35.28 | $882K |
| SWAIN PAULA J | EVP, Human Resources | 2013-09-05 | SELL | 94,444 | $35.06 | $3311.2K |
| WHITFIELD ROY A | Director | 2013-08-19 | SELL | 50,000 | $26.7 | $1335K |
| WHITFIELD ROY A | Director | 2013-05-17 | SELL | 40,000 | $23.08 | $923.2K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2013-05-13 | SELL | 55,699 | $22.3 | $1242.1K |
| WHITFIELD ROY A | Director | 2013-03-14 | SELL | 10,000 | $25.08 | $250.8K |
| WHITFIELD ROY A | Director | 2013-03-01 | SELL | 10,000 | $22.56 | $225.6K |
| Siegel Eric H. | EVP, General Counsel | 2013-02-28 | SELL | 50,000 | $22.16 | $1108K |
| SWAIN PAULA J | EVP, Human Resources | 2013-02-20 | SELL | 103,283 | $21.53 | $2223.7K |
| WHITFIELD ROY A | Director | 2013-02-19 | SELL | 30,000 | $21.82 | $654.6K |
| HASTINGS DAVID C | CFO | 2013-02-15 | SELL | 100,000 | $22.52 | $2252K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2013-02-15 | SELL | 98,440 | $22.48 | $2212.9K |
| DE SCHUTTER RICHARD U | Chairman | 2012-12-17 | SELL | 50,000 | $16.03 | $801.5K |
| Chardonnet Laurent | Vice President and Treasurer | 2012-07-05 | SELL | 35,700 | $25.11 | $896.4K |
| Chardonnet Laurent | Vice President and Treasurer | 2012-07-02 | SELL | 36,666 | $24.15 | $885.5K |
| WHITFIELD ROY A | Director | 2012-05-24 | SELL | 20,000 | $22.27 | $445.4K |
| BROOKE PAUL A | Director | 2012-05-16 | SELL | 5,000 | $23.55 | $117.8K |
| Siegel Eric H. | EVP, General Counsel | 2012-05-14 | SELL | 57,481 | $23.12 | $1329K |
| SWAIN PAULA J | EVP, Human Resources | 2012-05-11 | SELL | 147,389 | $23.22 | $3422.4K |
| FRIEDMAN PAUL A | CEO | 2012-05-07 | SELL | 225,000 | $22.56 | $5076K |
| Chardonnet Laurent | Vice President and Treasurer | 2012-05-01 | SELL | 13,976 | $22.7 | $317.3K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2012-04-27 | SELL | 30,000 | $22.95 | $688.5K |
| WHITFIELD ROY A | Director | 2012-02-17 | SELL | 20,000 | $17.53 | $350.6K |
| BROOKE PAUL A | Director | 2012-01-19 | BUY | 50,000 | $17.7 | $885K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2012-01-13 | BUY | 14,625 | $16.37 | $239.4K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2012-01-13 | BUY | 543,239 | $16.37 | $8892.8K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2011-12-09 | BUY | 403,521 | $13.37 | $5395.1K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2011-12-09 | BUY | 10,827 | $13.37 | $144.8K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2011-12-07 | BUY | 41,620 | $13.75 | $572.3K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2011-12-07 | BUY | 1,555,134 | $13.75 | $21383.1K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2011-12-01 | BUY | 51,270 | $13.04 | $668.6K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2011-12-01 | BUY | 2,406,179 | $13.13 | $31593.1K |
| DIXON WENDY L | Director | 2011-11-17 | BUY | 7,500 | $13.4 | $100.5K |
| Chardonnet Laurent | Vice President and Treasurer | 2011-06-21 | SELL | 40,000 | $18.61 | $744.4K |
| WHITFIELD ROY A | Director | 2011-06-17 | SELL | 20,000 | $18.02 | $360.4K |
| HASTINGS DAVID C | CFO | 2011-06-09 | SELL | 100,000 | $17.74 | $1774K |
| SWAIN PAULA J | EVP, Human Resources | 2011-05-17 | SELL | 75,000 | $19.3 | $1447.5K |
| WHITFIELD ROY A | Director | 2011-05-12 | SELL | 20,000 | $20.16 | $403.2K |
| SCHRECK PATRICIA A | EVP, General Counsel | 2011-05-10 | SELL | 100,000 | $20.24 | $2024K |
| WHITFIELD ROY A | Director | 2011-05-09 | SELL | 20,000 | $19.51 | $390.2K |
| Chardonnet Laurent | Vice President and Treasurer | 2011-05-06 | SELL | 5,343 | $19.55 | $104.5K |
| METCALF BRIAN W | Chief Drug Discovery Scientist | 2011-04-11 | SELL | 100,000 | $17.41 | $1741K |
| Chardonnet Laurent | Vice President and Treasurer | 2011-04-08 | SELL | 25,000 | $17.01 | $425.3K |
| SCHRECK PATRICIA A | EVP, General Counsel | 2011-04-07 | SELL | 100,000 | $16.5 | $1650K |
| WHITFIELD ROY A | Director | 2011-04-05 | SELL | 10,000 | $16.01 | $160.1K |
| WHITFIELD ROY A | Director | 2011-03-25 | SELL | 10,000 | $14.65 | $146.5K |
| METCALF BRIAN W | Chief Drug Discovery Scientist | 2011-03-18 | SELL | 210,000 | $14.26 | $2994.6K |
| METCALF BRIAN W | Chief Drug Discovery Scientist | 2011-02-17 | SELL | 50,000 | $14.35 | $717.5K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2011-01-18 | SELL | 40,310 | $15.8 | $636.9K |
| WHITFIELD ROY A | Director | 2010-12-23 | SELL | 20,000 | $17.01 | $340.2K |
| WHITFIELD ROY A | Director | 2010-11-17 | SELL | 11,000 | $15.99 | $175.9K |
| WHITFIELD ROY A | Director | 2010-10-25 | SELL | 34,253 | $16.97 | $581.3K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2010-09-23 | SELL | 1,016,787 | $14.88 | $15129.8K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2010-09-23 | SELL | 32,152 | $14.88 | $478.4K |
| Baker Biotech Capital (GP), LL | Director, 10% Owner | 2010-09-23 | SELL | 397,050 | $14.88 | $5908.1K |
| Baker Bros. Capital (GP), LLC | Director, 10% Owner | 2010-09-23 | SELL | 32,388 | $14.88 | $481.9K |
| Baker / Tisch Capital (GP), LL | Director, 10% Owner | 2010-09-23 | SELL | 21,623 | $14.88 | $321.8K |
| Baker Bros. Capital (GP), LLC | Director, 10% Owner | 2010-08-10 | SELL | 12,803 | $14.06 | $180K |
| Baker / Tisch Capital (GP), LL | Director, 10% Owner | 2010-08-10 | SELL | 8,547 | $14.06 | $120.2K |
| Baker Biotech Capital (GP), LL | Director, 10% Owner | 2010-08-10 | SELL | 156,929 | $14.06 | $2206.4K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2010-08-10 | SELL | 401,872 | $14.06 | $5650.3K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2010-08-10 | SELL | 12,705 | $14.07 | $178.8K |
| Chardonnet Laurent | Vice President and Treasurer | 2010-08-09 | SELL | 15,618 | $14.06 | $219.6K |
| SCHRECK PATRICIA A | EVP, General Counsel | 2010-08-06 | SELL | 94,960 | $13.88 | $1318K |
| HASTINGS DAVID C | CFO | 2010-07-01 | BUY | 2,000 | $10.24 | $20.5K |
| FRIEDMAN PAUL A | CEO | 2010-07-01 | BUY | 10,000 | $10.43 | $104.3K |
| SWAIN PAULA J | EVP, Human Resources | 2010-06-17 | SELL | 97,917 | $13.15 | $1287.6K |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2010-03-15 | SELL | 20,000 | $12.94 | $258.8K |
| Friedman Steven M. | EVP, Biology & Preclinical Dev | 2010-01-08 | SELL | 22,000 | $10.9 | $239.8K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2009-03-05 | BUY | 20,756 | $2.15 | $44.6K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2009-03-05 | BUY | 576 | $2.15 | $1.2K |
| FRIEDMAN PAUL A | CEO | 2009-03-05 | BUY | 20,000 | $2.2 | $44K |
| Baker / Tisch Capital (GP), LL | Director, 10% Owner | 2009-03-05 | BUY | 162 | $2.15 | $0.3K |
| Baker Biotech Capital (GP), LL | Director, 10% Owner | 2009-03-05 | BUY | 3,447 | $2.15 | $7.4K |
| Baker Bros. Capital (GP), LLC | Director, 10% Owner | 2009-03-05 | BUY | 10 | $2.15 | $0K |
| Baker Biotech Capital (GP), LL | Director, 10% Owner | 2009-03-02 | BUY | 7,701 | $2.15 | $16.6K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2009-03-02 | BUY | 927 | $2.15 | $2K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2009-03-02 | BUY | 33,364 | $2.15 | $71.7K |
| Baker Bros. Capital (GP), LLC | Director, 10% Owner | 2009-03-02 | BUY | 17 | $2.15 | $0K |
| Baker / Tisch Capital (GP), LL | Director, 10% Owner | 2009-03-02 | BUY | 343 | $2.15 | $0.7K |
| Baker Biotech Capital (GP), LL | Director, 10% Owner | 2008-12-22 | BUY | 227,282 | $3.5 | $795.5K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2008-12-22 | BUY | 20,088 | $3.51 | $70.5K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2008-12-22 | BUY | 735,417 | $3.51 | $2581.3K |
| Baker Biotech Capital (GP), LL | Director, 10% Owner | 2008-12-19 | BUY | 227,270 | $3.5 | $795.4K |
| Baker Bros. Capital (GP), LLC | Director, 10% Owner | 2008-12-19 | BUY | 1,896 | $3.55 | $6.7K |
| Baker / Tisch Capital (GP), LL | Director, 10% Owner | 2008-12-19 | BUY | 5,056 | $3.51 | $17.7K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2008-12-19 | BUY | 20,085 | $3.51 | $70.5K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2008-12-19 | BUY | 735,332 | $3.51 | $2581K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2008-12-19 | BUY | 735,332 | $3.51 | $2581K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2008-12-19 | BUY | 20,085 | $3.51 | $70.5K |
| Baker Bros. Capital (GP), LLC | Director, 10% Owner | 2008-12-19 | BUY | 839 | $3.49 | $2.9K |
| Baker / Tisch Capital (GP), LL | Director, 10% Owner | 2008-12-19 | BUY | 5,056 | $3.51 | $17.7K |
| Chardonnet Laurent | Vice President and Treasurer | 2008-11-20 | BUY | 8,000 | $2.71 | $21.7K |
| HASTINGS DAVID C | CFO | 2008-11-20 | BUY | 4,000 | $2.36 | $9.4K |
| SCHRECK PATRICIA A | EVP, General Counsel | 2008-11-20 | BUY | 2,500 | $2.44 | $6.1K |
| FRIEDMAN PAUL A | CEO | 2008-11-20 | BUY | 13,000 | $2.55 | $33.2K |
| FRIEDMAN PAUL A | CEO, Director | 2008-10-15 | BUY | 10,000 | $4.95 | $49.5K |
| Baker Biotech Capital (GP), LL | Director, 10% Owner | 2008-07-31 | BUY | 201,648 | $9 | $1814.8K |
| Baker Bros. Capital (GP), LLC | Director, 10% Owner | 2008-07-31 | BUY | 1,539 | $9 | $13.9K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2008-07-31 | BUY | 864,092 | $9 | $7776.8K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2008-07-31 | BUY | 27,724 | $9 | $249.5K |
| Baker / Tisch Capital (GP), LL | Director, 10% Owner | 2008-07-31 | BUY | 4,997 | $9 | $45K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2008-01-22 | BUY | 7 | $10.62 | $0.1K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2008-01-22 | BUY | 223 | $10.62 | $2.4K |
| Baker Biotech Capital (GP), LL | Director, 10% Owner | 2008-01-22 | BUY | 65 | $10.62 | $0.7K |
| Baker / Tisch Capital (GP), LL | Director, 10% Owner | 2008-01-22 | BUY | 4 | $10.62 | $0K |
| Baker Bros. Capital (GP), LLC | Director, 10% Owner | 2008-01-22 | BUY | 1 | $10.62 | $0K |
| Baker Bros. Capital (GP), LLC | Director, 10% Owner | 2008-01-14 | BUY | 94 | $10.99 | $1K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2008-01-14 | BUY | 34,621 | $10.99 | $380.5K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2008-01-14 | BUY | 1,101 | $10.99 | $12.1K |
| Baker Biotech Capital (GP), LL | Director, 10% Owner | 2008-01-14 | BUY | 13,675 | $10.99 | $150.3K |
| Baker / Tisch Capital (GP), LL | Director, 10% Owner | 2008-01-14 | BUY | 723 | $10.99 | $7.9K |
| Baker Bros. Capital (GP), LLC | Director, 10% Owner | 2008-01-11 | BUY | 334 | $10.94 | $3.7K |
| Baker Biotech Capital (GP), LL | Director, 10% Owner | 2008-01-11 | BUY | 48,393 | $10.94 | $529.4K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2008-01-11 | BUY | 122,514 | $10.94 | $1340.3K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2008-01-11 | BUY | 3,891 | $10.94 | $42.6K |
| Baker / Tisch Capital (GP), LL | Director, 10% Owner | 2008-01-11 | BUY | 2,559 | $10.94 | $28K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2008-01-08 | BUY | 993,832 | $10.14 | $10077.5K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2008-01-08 | BUY | 31,573 | $10.14 | $320.2K |
| Baker Biotech Capital (GP), LL | Director, 10% Owner | 2008-01-08 | BUY | 392,571 | $10.14 | $3980.7K |
| Baker / Tisch Capital (GP), LL | Director, 10% Owner | 2008-01-08 | BUY | 20,749 | $10.14 | $210.4K |
| Baker Bros. Capital (GP), LLC | Director, 10% Owner | 2008-01-08 | BUY | 2,712 | $10.14 | $27.5K |
| Baker / Tisch Capital (GP), LL | Director, 10% Owner | 2007-12-19 | BUY | 4,960 | $10.6 | $52.6K |
| Baker Bros. Capital (GP), LLC | Director, 10% Owner | 2007-12-19 | BUY | 648 | $10.6 | $6.9K |
| Baker Biotech Capital (GP), LL | Director, 10% Owner | 2007-12-19 | BUY | 93,849 | $10.6 | $994.8K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2007-12-19 | BUY | 237,587 | $10.6 | $2518.4K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2007-12-19 | BUY | 7,549 | $10.6 | $80K |
| Baker Brothers Life Sciences C | Director, 10% Owner | 2007-12-12 | BUY | 433,415 | $9.99 | $4329.8K |
| 14159 capital (GP), LLC | Director, 10% Owner | 2007-12-12 | BUY | 13,769 | $9.99 | $137.6K |
| Baker Bros. Capital (GP), LLC | Director, 10% Owner | 2007-12-12 | BUY | 1,183 | $9.99 | $11.8K |
| Baker / Tisch Capital (GP), LL | Director, 10% Owner | 2007-12-12 | BUY | 9,049 | $9.99 | $90.4K |
| Baker Biotech Capital (GP), LL | Director, 10% Owner | 2007-12-12 | BUY | 171,202 | $9.99 | $1710.3K |
| Baker Biotech Capital (GP), LL | Director | 2007-12-12 | BUY | 171,202 | $9.99 | $1710.3K |
| Baker / Tisch Capital (GP), LL | Director | 2007-12-12 | BUY | 9,049 | $9.99 | $90.4K |
| Baker / Tisch Capital (GP), LL | Director | 2007-12-04 | BUY | 1,139 | $8.98 | $10.2K |
| Baker Biotech Capital (GP), LL | Director | 2007-12-04 | BUY | 19,593 | $8.98 | $175.9K |
| 14159 capital (GP), LLC | Director | 2007-12-04 | BUY | 1,812 | $8.98 | $16.3K |
| Baker Brothers Life Sciences C | Director | 2007-12-04 | BUY | 57,303 | $8.98 | $514.6K |
| Baker Bros. Capital (GP), LLC | Director | 2007-12-04 | BUY | 153 | $8.98 | $1.4K |
| Baker Biotech Capital (GP), LL | Director | 2007-12-03 | BUY | 17,130 | $8.68 | $148.7K |
| 14159 capital (GP), LLC | Director | 2007-12-03 | BUY | 3,043 | $8.68 | $26.4K |
| Baker Brothers Life Sciences C | Director | 2007-12-03 | BUY | 96,313 | $8.68 | $836K |
| Baker Bros. Capital (GP), LLC | Director | 2007-12-03 | BUY | 258 | $8.68 | $2.2K |
| Baker Bros. Capital (GP), LLC | Director | 2007-11-28 | BUY | 1,102 | $8.11 | $8.9K |
| Baker Biotech Capital (GP), LL | Director | 2007-11-28 | BUY | 73,260 | $8.11 | $594.1K |
| Baker Brothers Life Sciences C | Director | 2007-11-28 | BUY | 411,940 | $8.11 | $3340.8K |
| 14159 capital (GP), LLC | Director | 2007-11-28 | BUY | 13,019 | $8.11 | $105.6K |
| Baker Biotech Capital (GP), LL | Director | 2007-11-21 | BUY | 70,742 | $8.18 | $578.7K |
| Baker Brothers Life Sciences C | Director | 2007-11-21 | BUY | 278,911 | $8.17 | $2278.7K |
| 14159 capital (GP), LLC | Director | 2007-11-21 | BUY | 8,814 | $8.17 | $72K |
| Baker Bros. Capital (GP), LLC | Director | 2007-11-21 | BUY | 747 | $8.17 | $6.1K |
| Baker / Tisch Capital (GP), LL | Director | 2007-11-19 | BUY | 318 | $8.22 | $2.6K |
| 14159 capital (GP), LLC | Director | 2007-11-16 | BUY | 10,664 | $8.49 | $90.5K |
| Baker Brothers Life Sciences C | Director | 2007-11-16 | BUY | 337,456 | $8.49 | $2865K |
| Baker Biotech Capital (GP), LL | Director | 2007-11-16 | BUY | 126,099 | $8.5 | $1071.8K |
| Baker Bros. Capital (GP), LLC | Director | 2007-11-16 | BUY | 904 | $8.49 | $7.7K |
| Baker / Tisch Capital (GP), LL | Director | 2007-11-16 | BUY | 1,053 | $8.51 | $9K |
| Baker / Tisch Capital (GP), LL | Director | 2007-11-13 | BUY | 2,442 | $8.09 | $19.8K |
| 14159 capital (GP), LLC | Director | 2007-11-13 | BUY | 21,926 | $8.09 | $177.4K |
| Baker Biotech Capital (GP), LL | Director | 2007-11-13 | BUY | 274,182 | $8.09 | $2218.1K |
| Baker Brothers Life Sciences C | Director | 2007-11-13 | BUY | 693,773 | $8.09 | $5612.6K |
| Baker Bros. Capital (GP), LLC | Director | 2007-11-13 | BUY | 1,857 | $8.09 | $15K |
| FRIEDMAN PAUL A | CEO | 2007-08-17 | BUY | 16,665 | $5.47 | $91.2K |
| 14159 capital (GP), LLC | Director | 2007-08-03 | BUY | 14,365 | $4.91 | $70.5K |
| Baker Biotech Capital (GP), LL | Director | 2007-08-03 | BUY | 171,332 | $4.91 | $841.2K |
| Baker Brothers Life Sciences C | Director | 2007-08-03 | BUY | 451,861 | $4.91 | $2218.6K |
| Baker Bros. Capital (GP), LLC | Director | 2007-08-03 | BUY | 1,151 | $4.91 | $5.7K |
| SWAIN PAULA J | EVP, Human Resources | 2006-04-06 | BUY | 3,000 | $3.65 | $11K |
| FRIEDMAN PAUL A | CEO | 2006-04-04 | BUY | 5,500 | $3.56 | $19.6K |
| HASTINGS DAVID C | CFO | 2006-04-04 | BUY | 2,500 | $3.6 | $9K |
| SCHRECK PATRICIA A | EVP, General Counsel | 2006-04-04 | BUY | 2,000 | $3.59 | $7.2K |
| FRIEDMAN PAUL A | CEO | 2005-08-23 | BUY | 2,700 | $7.24 | $19.5K |
| DE SCHUTTER RICHARD U | Director | 2005-03-09 | BUY | 20,000 | $7.05 | $141K |
| BAKER JULIAN | Director | 2004-11-01 | BUY | 300,000 | $9.75 | $2925K |
| BROOKE PAUL A | Director | 2004-09-09 | BUY | 100,000 | $7.74 | $774K |
| FRIEDMAN PAUL A | CEO | 2004-08-16 | BUY | 3,500 | $5.62 | $19.7K |
| TISCH DANIEL R | 10% Owner | 2004-08-12 | BUY | 255,750 | $5.5 | $1406.6K |
| TISCH ANDREW H | 10% Owner | 2004-08-12 | BUY | 255,750 | $5.5 | $1406.6K |
| TISCH JAMES S | 10% Owner | 2004-08-12 | BUY | 255,750 | $5.5 | $1406.6K |
| TISCH THOMAS J | 10% Owner | 2004-08-12 | BUY | 255,750 | $5.5 | $1406.6K |
| BAKER BROS CAPITAL GP LLC | 10% Owner | 2003-09-22 | BUY | 13,800 | $4.97 | $68.6K |
| BAKER BIOTECH CAPITAL II GP LL | 10% Owner | 2003-09-22 | BUY | 71,100 | $4.97 | $353.4K |
| BAKER BIOTECH CAPITAL GP LLC | 10% Owner | 2003-09-22 | BUY | 67,300 | $4.97 | $334.5K |
| BAKER BROS CAPITAL GP LLC | 10% Owner | 2003-09-19 | BUY | 107,650 | $5.04 | $542.6K |
| BAKER BIOTECH CAPITAL GP LLC | 10% Owner | 2003-09-19 | BUY | 526,000 | $5.04 | $2651K |
| BAKER BIOTECH CAPITAL II GP LL | 10% Owner | 2003-09-19 | BUY | 556,350 | $5.04 | $2804K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked